These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 18606253

  • 21. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM.
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [Abstract] [Full Text] [Related]

  • 22. Analysis of Anti-C1q Autoantibodies by Western Blot.
    Verlemyr A, Truedsson L, Skattum L.
    Methods Mol Biol; 2019 Sep; 1901():183-189. PubMed ID: 30539577
    [Abstract] [Full Text] [Related]

  • 23. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.
    Mevorach D.
    Apoptosis; 2010 Sep; 15(9):1114-23. PubMed ID: 20683667
    [Abstract] [Full Text] [Related]

  • 24. Autoantibodies against complement C1q in acute post-streptococcal glomerulonephritis.
    Kozyro I, Korosteleva L, Chernoshej D, Danner D, Sukalo A, Trendelenburg M.
    Clin Immunol; 2008 Sep; 128(3):409-14. PubMed ID: 18544473
    [Abstract] [Full Text] [Related]

  • 25. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
    Bigler C, Hopfer H, Danner D, Schaller M, Mihatsch MJ, Trendelenburg M.
    Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491
    [Abstract] [Full Text] [Related]

  • 26. New insight into the autoimmunogenicity of the complement protein C1q.
    Stoyanova V, Petrova S, Tchorbadjieva M, Deliyska B, Vasilev V, Tsacheva I.
    Mol Immunol; 2011 Jan; 48(4):678-82. PubMed ID: 21159384
    [Abstract] [Full Text] [Related]

  • 27. C1q, autoimmunity and apoptosis.
    Botto M, Walport MJ.
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [Abstract] [Full Text] [Related]

  • 28. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I, Radanova M, Todorova N, Argirova T, Kishore U.
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [Abstract] [Full Text] [Related]

  • 29. Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis.
    Trouw LA, Daha MR.
    Expert Opin Biol Ther; 2005 Feb; 5(2):243-51. PubMed ID: 15757386
    [Abstract] [Full Text] [Related]

  • 30. [Ecchymotic angioedema revealing childhood systemic lupus erythematosus with anti-C1q antibodies].
    Frot AS, Barbarot S, Poignant S, Guyot C, Stalder JF.
    Ann Dermatol Venereol; 2008 Feb; 135(8-9):584-6. PubMed ID: 18789294
    [Abstract] [Full Text] [Related]

  • 31. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein.
    Yang XW, Tan Y, Yu F, Zhao MH.
    Hum Immunol; 2012 Feb; 73(2):156-63. PubMed ID: 22192784
    [Abstract] [Full Text] [Related]

  • 32. [Is autoantibody determination in patients with systemic lupus erythematosus useful? Anti-C1q-autoantibody as an example].
    Trendelenburg M, Schifferli JA.
    Praxis (Bern 1994); 1998 Dec 24; 87(51-52):1811-3. PubMed ID: 10025155
    [Abstract] [Full Text] [Related]

  • 33. Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.
    Arason GJ, Kolka R, Hreidarsson AB, Gudjonsson H, Schneider PM, Fry L, Arnason A.
    Clin Exp Immunol; 2005 Jun 24; 140(3):572-9. PubMed ID: 15932521
    [Abstract] [Full Text] [Related]

  • 34. [Apoptosis and C1q: possible explanations for the pathogenesis of systemic lupus erythematosus].
    Trendelenburg M, Schifferli JA.
    Z Rheumatol; 2000 Jun 24; 59(3):172-5. PubMed ID: 10929445
    [Abstract] [Full Text] [Related]

  • 35. Study of Anti-C1q Antibodies in Egyptian Systemic Lupus Erythematosus Patients.
    Eldin RE, Marie MA.
    Saudi J Kidney Dis Transpl; 2022 Jun 24; 33(1):66-71. PubMed ID: 36647980
    [Abstract] [Full Text] [Related]

  • 36. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.
    Trouw LA, Groeneveld TW, Seelen MA, Duijs JM, Bajema IM, Prins FA, Kishore U, Salant DJ, Verbeek JS, van Kooten C, Daha MR.
    J Clin Invest; 2004 Sep 24; 114(5):679-88. PubMed ID: 15343386
    [Abstract] [Full Text] [Related]

  • 37. Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in mice.
    Cortes-Hernandez J, Fossati-Jimack L, Petry F, Loos M, Izui S, Walport MJ, Cook HT, Botto M.
    Eur J Immunol; 2004 Dec 24; 34(12):3713-22. PubMed ID: 15517607
    [Abstract] [Full Text] [Related]

  • 38. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.
    Jesus AA, Silva CA, Carneiro-Sampaio M, Sheinberg M, Mangueira CL, Marie SK, Liphaus BL.
    Ann N Y Acad Sci; 2009 Sep 24; 1173():235-8. PubMed ID: 19758156
    [Abstract] [Full Text] [Related]

  • 39. C1q, antibodies and anti-C1q autoantibodies.
    Beurskens FJ, van Schaarenburg RA, Trouw LA.
    Mol Immunol; 2015 Nov 24; 68(1):6-13. PubMed ID: 26032012
    [Abstract] [Full Text] [Related]

  • 40. Biochemical analysis of the epitope specificities of anti-C1q autoantibodies accompanying human lupus nephritis reveals them as a dynamic population in the course of the disease.
    Stoyanova V, Tchorbadjieva M, Deliyska B, Vasilev V, Tsacheva I.
    Immunol Lett; 2012 Nov 24; 148(1):69-76. PubMed ID: 22981967
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.